0001708138-20-000088.txt : 20200715 0001708138-20-000088.hdr.sgml : 20200715 20200715165152 ACCESSION NUMBER: 0001708138-20-000088 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200713 FILED AS OF DATE: 20200715 DATE AS OF CHANGE: 20200715 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MURPHY ANDREW J CENTRAL INDEX KEY: 0001796226 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19034 FILM NUMBER: 201029819 MAIL ADDRESS: STREET 1: REGENERON PHARMACEUTICALS, INC. STREET 2: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0000872589 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133444607 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 BUSINESS PHONE: 9148477000 MAIL ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 FORMER COMPANY: FORMER CONFORMED NAME: REGENERON PHARMACEUTICALS INC DATE OF NAME CHANGE: 19930328 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2020-07-13 0 0000872589 REGENERON PHARMACEUTICALS, INC. REGN 0001796226 MURPHY ANDREW J 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 0 1 0 0 EVP Research Common Stock 2020-07-14 4 S 0 264 630.77 D 44067 D Common Stock 2020-07-14 4 S 0 578 631.32 D 43489 D Common Stock 2020-07-14 4 S 0 679 632.12 D 42810 D Common Stock 2020-07-14 4 S 0 95 633.02 D 42715 D Common Stock 2020-07-14 4 S 0 89 634.18 D 42626 D Common Stock 2020-07-14 4 S 0 175 635.46 D 42451 D Common Stock 2020-07-14 4 S 0 182 637.48 D 42269 D Common Stock 2020-07-14 4 S 0 239 638.96 D 42030 D Common Stock 2020-07-14 4 S 0 79 639.55 D 41951 D Common Stock 4242 I By 401(k) Plan Non-Qualified Stock Option (right to buy) 30.63 2020-07-13 4 M 0 13000 0.0 D 2020-12-14 Common Stock 13000 13736 D Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Represents volume-weighted average price of sales of 578 shares of Company stock on July 14, 2020 at prices ranging from $631.07 to $631.43. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 14, 2020 at each separate price. Represents volume-weighted average price of sales of 679 shares of Company stock on July 14, 2020 at prices ranging from $632.04 to $632.78. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 14, 2020 at each separate price. Represents volume-weighted average price of sales of 175 shares of Company stock on July 14, 2020 at prices ranging from $635.29 to $635.61. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 14, 2020 at each separate price. Represents volume-weighted average price of sales of 182 shares of Company stock on July 14, 2020 at prices ranging from $637.19 to $637.68. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 14, 2020 at each separate price. Represents volume-weighted average price of sales of 239 shares of Company stock on July 14, 2020 at prices ranging from $638.87 to $638.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 14, 2020 at each separate price. The stock option award vests in four equal annual installments, commencing one year after the date of grant. Form two of two /s/**Andrew Murphy 2020-07-14